De Gregorio M - Search Results

1

Phase II double-blind randomized study of lonidamine and radiotherapy in epidermoid carcinoma of the lung.

Privitera G, Ciottoli GB, Patanè C, Palmucci T, Tafuri G, Marletta F, De Luca B, Magnani F, De Gregorio M, Greco S. Privitera G, et al. Among authors: de gregorio m, de luca b. Radiother Oncol. 1987 Dec;10(4):285-90. doi: 10.1016/s0167-8140(87)80034-8. Radiother Oncol. 1987. PMID: 3444905 Clinical Trial.

2

Chemotherapy/radiation therapy plus/minus lonidamine in the treatment of non-small cell lung cancer (limited disease): preliminary results.

Gallo-Curcio C, Verturo I, Rinaldi M, Ambesi Impiombato F, Del Vecchio MR, Tonachella R, Tropea F, Antilli A, Ciottoli GB, De Gregorio M, et al. Gallo-Curcio C, et al. Among authors: de gregorio m. Semin Oncol. 1988 Dec;15(6 Suppl 7):26-31. Semin Oncol. 1988. PMID: 2851173 Clinical Trial.

3

Phase II study of lonidamine in inoperable non-small-cell lung cancer.

Kokron O, Maca S, Scheiner W, De Gregorio M, Ciottoli GB. Kokron O, et al. Among authors: de gregorio m. Oncology. 1984;41 Suppl 1:86-9. doi: 10.1159/000225893. Oncology. 1984. PMID: 6717902

4

Phase II study of lonidamine in non-small cell lung cancer: final report.

Kokron O, Maca S, De Gregorio M, Ciottoli GB. Kokron O, et al. Among authors: de gregorio m. Br J Cancer. 1990 Feb;61(2):316-8. doi: 10.1038/bjc.1990.60. Br J Cancer. 1990. PMID: 2155644 Free PMC article.

5

A long-term clinical experience with Lonidamine.

Battelli T, Manocchi P, Giustini L, Mattioli R, Ginnetti A, De Gregorio M, De Martino C, Silvestrini B. Battelli T, et al. Among authors: de gregorio m, de martino c. Oncology. 1984;41 Suppl 1:39-47. doi: 10.1159/000225884. Oncology. 1984. PMID: 6717894

6

Lonidamine in head and neck cancer: an overview.

Scarantino CW, Newton RE, Paggiarino DA, DeGregorio M. Scarantino CW, et al. Semin Oncol. 1991 Apr;18(2 Suppl 4):28-32. Semin Oncol. 1991. PMID: 2031195 Review.

7

Lonidamine and related compounds.

Silvestrini B, Palazzo G, De Gregorio M. Silvestrini B, et al. Among authors: de gregorio m. Prog Med Chem. 1984;21:110-35. Prog Med Chem. 1984. PMID: 6400133 Review. No abstract available.

8

Cisplatin dose intensity in non-small cell lung cancer: phase II results of a day 1 and day 8 high-dose regimen.

Gandara DR, Wold H, Perez EA, Deisseroth AB, Doroshow J, Meyers F, McWhirter K, Hannigan J, De Gregorio MW. Gandara DR, et al. Among authors: de gregorio mw. J Natl Cancer Inst. 1989 May 10;81(10):790-4. doi: 10.1093/jnci/81.10.790. J Natl Cancer Inst. 1989. PMID: 2541260

9

High-dose cisplatin in hypertonic saline: reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California Oncology Group Pilot Study in non-small-cell lung cancer.

Gandara DR, DeGregorio MW, Wold H, Wilbur BJ, Kohler M, Lawrence HJ, Deisseroth AB, George CB. Gandara DR, et al. J Clin Oncol. 1986 Dec;4(12):1787-93. doi: 10.1200/JCO.1986.4.12.1787. J Clin Oncol. 1986. PMID: 3023557

10

High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically.

Lara PN Jr, Gandara DR, Wurz GT, Lau D, Uhrich M, Turrell C, Raschko J, Edelman MJ, Synold T, Doroshow J, Muggia F, Perez EA, DeGregorio M. Lara PN Jr, et al. Cancer Chemother Pharmacol. 1998;42(6):504-8. doi: 10.1007/s002800050852. Cancer Chemother Pharmacol. 1998. PMID: 9788578 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

333 results

Search Page

Filters